KBG Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Mar 02

CEO

KBG has no CEO, or we have no data on them.

KBG Management

Management criteria checks 0/4

Key information

Recent management updates

Korea Bio-Gen Co.,Ltd, Annual General Meeting, Mar 26, 2021

Recent updates

Inaugural dividend of ₩99.50 per share

New major risk - Share price stability

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 28%

Investor sentiment deteriorates as stock falls 18%

New minor risk - Shareholder dilution

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 57%

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 42%

Inaugural dividend of ₩100.00 per share

Third quarter 2022 earnings released: EPS: ₩169 (vs ₩117 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Inaugural dividend of ₩75.00 per share

Third quarter 2021 earnings released: EPS ₩117 (vs ₩121 in 3Q 2020)

Investor sentiment improved over the past week

Korea Bio-Gen Co.,Ltd announced that it has received KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor

Korea Bio-Gen Co.,Ltd announced that it expects to receive KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Korea Bio-Gen Co.,Ltd, Annual General Meeting, Mar 26, 2021

The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About

Investor sentiment improved over the past week

New 90-day high: ₩10,950

New 90-day high: ₩8,390

Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?

First Dividend Is ₩50.00 Per Share

Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)

New 90-day low: ₩6,880

New 90-day high - ₩7,500

CEO